Surviving as a rare disease biotech during COVID-19With trial delays, social distancing, and falls in charitable funding, the coronavirus pandemic presents some serious challenges for Share XSurviving as a rare disease biotech during COVID-19https://pharmaphorum.com/r-d/views-analysis-r-d/surviving-as-a-rare-disease-biotech-during-covid-19/
